KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) Other Operating Expenses (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Other Operating Expenses for 17 consecutive years, with $5.3 billion as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses fell 1.17% to $5.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.0 billion through Dec 2025, up 2.03% year-over-year, with the annual reading at $21.0 billion for FY2025, 2.03% up from the prior year.
  • Other Operating Expenses hit $5.3 billion in Q4 2025 for Abbott Laboratories, down from $5.5 billion in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $5.5 billion in Q1 2022 to a low of $4.8 billion in Q1 2023.
  • Historically, Other Operating Expenses has averaged $5.2 billion across 5 years, with a median of $5.1 billion in 2022.
  • Biggest five-year swings in Other Operating Expenses: skyrocketed 42.85% in 2021 and later fell 12.31% in 2023.
  • Year by year, Other Operating Expenses stood at $5.3 billion in 2021, then decreased by 3.62% to $5.1 billion in 2022, then fell by 1.02% to $5.0 billion in 2023, then rose by 7.35% to $5.4 billion in 2024, then fell by 1.17% to $5.3 billion in 2025.
  • Business Quant data shows Other Operating Expenses for ABT at $5.3 billion in Q4 2025, $5.5 billion in Q3 2025, and $5.3 billion in Q2 2025.